# Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction

> **NCT02291796** · PHASE4 · COMPLETED · sponsor: **Instituto Mexicano del Seguro Social** · enrollment: 100 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Bezafibrate

## Key facts

- **NCT ID:** NCT02291796
- **Lead sponsor:** Instituto Mexicano del Seguro Social
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02291796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02291796, "Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02291796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*